Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes
Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Ebaa Al‐Ozairi
,
Mohammad Irshad
,
Jumana AlKandari
,
Anant Mashankar
,
Dherar Alroudhan
,
Carel W. le Roux
Format:
Artículo Open Access
Published:
Wiley
2024
Subjects:
Diabetes, Obesity and Metabolism
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Description
DOI:
10.1111/dom.15760
Similar Items
Weight loss in people with type 1 diabetes over 12 months: Real‐world data comparing tirzepatide, semaglutide and liraglutide
by: Ebaa Al Ozairi, et al.
Published: (2025)
Association of device measured physical activity with liver fat and stiffness in people with type 1 diabetes
by: Ebaa Al Ozairi, et al.
Published: (2025)
Why do patients with obesity discontinue glucagon‐like peptide 1 analogues?
by: Faisal I. Almohaileb, et al.
Published: (2025)
Real world use of tirzepatide in the treatment of type 2 diabetes in an Arab population
by: Adam Buckley, et al.
Published: (2024)
Glucagon‐like peptide 1 ( GLP ‐1) receptor agonists' use during pregnancy: Safety data from regulatory clinical trials
by: Claire H. Parker, et al.
Published: (2025)